Synthetic development of radicicol and cycloproparadicicol: Highly promising anticancer agents targeting hsp90 Journal Article


Authors: Geng, X.; Yang, Z. Q.; Danishefsky, S. J.
Article Title: Synthetic development of radicicol and cycloproparadicicol: Highly promising anticancer agents targeting hsp90
Abstract: Molecular chaperone Hsp90 has emerged as one of the most exciting new targets for anticancer therapy. Natural product-based modulators, such as radicicol (1), inhibit Hsp90 and induce the breakdown of its client proteins, thereby blocking multiple critical oncogenic pathways. Several total synthesis endeavors directed toward radicicol have been accomplished. Cycloproparadicicol (2), a potent Hsp90 inhibitor and highly promising pre-clinical anticancer agent, was discovered through a convergent total synthesis approach. In an effort to devise a more efficient and concise route to reach 2, a novel 'ynolide' protocol, featuring an ynolide-bissiloxydiene Diels-Alder addition, was designed and reduced to practice. This methodology was also extended to aigialomycin D. 1 Introduction 2 First Total Synthesis of Radicicol 3 First Generation Convergent Total Synthesis of Radicicol and the Discovery of the Promising Anticancer Agent, Cycloproparadicicol 4 'Ynolide Approach': Second Generation Total Synthesis of Cycloproparadicicol 4.1 Development of 'Ynolide' Methodology 4.2 Scope and Limitations of the New Strategy 4.2.1 Extension of 'Ynolide Approach' to another Resorcinylic Macrolide: Aigialomycin D 4.2.2 Limitations 5 Conclusions and Future Directions.
Keywords: unclassified drug; antineoplastic agent; drug inhibition; antineoplastic activity; drug potency; drug synthesis; structure activity relation; heat shock protein 90; receptor blocking; antineoplastic antibiotic; diels alder reaction; radicicol; cycloproparadicicol; hsp90; chaperone; metastasis inhibition; anticancer; target cell destruction; article; ynolide; aigialomycin d
Journal Title: Synlett
Issue: 8
ISSN: 0936-5214
Publisher: Georg Thieme Verlag Kg  
Date Published: 2004-07-01
Start Page: 1325
End Page: 1333
Language: English
PROVIDER: scopus
DOI: 10.1055/s-2004-829052
DOI/URL:
Notes: Synlett -- Cited By (since 1996):26 -- Export Date: 16 June 2014 -- CODEN: SYNLE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Zhi-Qiang Yang
    5 Yang
  2. Xudong Geng
    6 Geng